Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Prognostic Factors In Uterine Adenosarcoma: Subanalysis Of The Sarcut Study

Prognostic factors in uterine adenosarcoma: subanalysis of the SARCUT study

Rosanna Mancari1, Yildirim Yusuf2, Ronalds Macuks3

  • 1Gynecologic Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Frontiers in Oncology
|June 5, 2024

Related Experiment Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

250
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.1K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.6K

View abstract on PubMed

Summary
This summary is machine-generated.

Age and FIGO stage are key prognostic factors for uterine adenosarcoma survival. Early relapse is linked to larger tumors and advanced stage, but treatment with surgery or radiotherapy can improve outcomes.

Area of Science:

  • Gynecologic Oncology
  • Surgical Pathology
  • Clinical Oncology

Background:

  • Uterine adenosarcoma is a rare malignant müllerian tumor.
  • Understanding prognostic factors is crucial for patient management and outcome prediction.

Purpose of the Study:

  • To analyze prognostic factors influencing recurrence risk and overall survival in uterine adenosarcoma patients.
  • To identify key clinical and pathological features associated with disease progression.

Main Methods:

  • Retrospective international multicenter study.
  • Inclusion of 32 uterine adenosarcoma cases from 46 centers.
  • Analysis of clinical, demographic, tumor characteristics, treatment, and survival data.

Main Results:

Keywords:
adenosarcomadisease-free survivalprognosissurvival rate

Related Experiment Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

250
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.1K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.6K
  • Five-year disease-free survival (DFS) was 85.3% and overall survival (OS) was 89.5%.
  • Significant prognostic factors for OS included patient age and FIGO stage (II-III).
  • Early relapse (<12 months) correlated with tumor size >30 mm and advanced stage.

    • Conclusions:

    • Age and FIGO stage are the most significant prognostic factors for uterine adenosarcoma.
    • Tumor size is an indirect prognostic indicator.
    • Adjuvant therapy with surgery and/or radiotherapy may improve disease-free status.
    uterine neoplasms